<DOC>
	<DOCNO>NCT02741609</DOCNO>
	<brief_summary>This study evaluate Advanced Laboratory Services Borrelia diagnostic test culture Borrelia spirochetes human serum subject early late Lyme disease . This 8 month study . Subjects enter study two blood sample collect one month apart early Lyme disease one blood sample collect late Lyme disease . Subjects sign IRB-approved consent form meet inclusion exclusion criterion enter study . Subjects assign subject number upon entry number retain throughout study .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Borrelia Diagnostic Test Subjects With Early Stage Late Stage Lyme Disease</brief_title>
	<detailed_description />
	<mesh_term>Lyme Disease</mesh_term>
	<criteria>1 . Subject must provide write informed consent prior conduct studyrelated procedure . 2 . Male female subject least 18 year age . 3 . Have early Lyme disease base follow criterion : Signs , symptoms clinical history consistent early stage Lyme disease . Subjects must physiciandiagnosed erythema migrans ( EM ) rash systemic symptom indicative disseminated infection . Symptoms may include fever , headache , fatigue , myalgia , arthralgia , stiff neck . Paired acute convalescent titer draw ( first draw time initial visit second draw 4 week later ) , 4 . Have late Lyme disease base follow criterion : Signs , symptoms clinical history consistent late stage Lyme disease , include limited disseminated rash , arthritis , meningitis , facial palsy , carditis . 5 . Subjects must willing ability safely required quantity blood drawn study discretion investigator . 6 . Subjects must blood sample freshly collect ( supplemental frozen sample ) sample must reach ALSI 's laboratory weekday within 24 hour draw . 1 . Early Lyme disease : Subjects without EM rash symptom recognize associated Lyme disease . 2 . Exposure antibiotic type 6 week prior initial blood sample collection . 3 . Immune deficiency significant enough render serological test less reliable . 4 . The subject unwilling unable safely required quantity blood drawn study . 5 . Subjects able understand requirement study unable give inform consent and/or comply aspects evaluation . 6 . Subjects condition situation , opinion investigator , would make subject unsuitable enrollment could interfere subject participate completing study . 7 . Subjects undergone test Lyme disease within past year . 8 . Subjects prior diagnosis Lyme disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Borrelia</keyword>
	<keyword>spirochete</keyword>
	<keyword>culture</keyword>
	<keyword>immunostaining</keyword>
</DOC>